Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
129,668,560
-
Total 13F shares
-
122,604,113
-
Share change
-
-891,828
-
Total reported value
-
$2,020,331,999
-
Put/Call ratio
-
14%
-
Price per share
-
$16.48
-
Number of holders
-
246
-
Value change
-
-$11,997,859
-
Number of buys
-
92
-
Number of sells
-
128
Institutional Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q4 2024
As of 31 Dec 2024 NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) had 246 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 122,604,113 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., JANUS HENDERSON GROUP PLC, BROWN ADVISORY INC, STATE STREET CORP, Greenhouse Funds LLLP, MACQUARIE GROUP LTD, SCHRODER INVESTMENT MANAGEMENT GROUP, and DIMENSIONAL FUND ADVISORS LP.
This table shows 248 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.